SCHEMBL19197992

SCHEMBL19197992

CN1C(=O)NC(C)(Cc2c[nH]c3ccccc23)C1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.50
KMT2A Q03164 4/20 0.50
KDM4E B2RXH2 2/20 0.50
ALDH1A1 P00352 2/20 0.50
POLB P06746 1/20 0.50
HPGD P15428 1/20 0.50
CYP3A4 P08684 4/20 0.46
HSD17B10 Q99714 2/20 0.46
TP53 P04637 1/20 0.46
GLA P06280 1/20 0.46
THRB P10828 1/20 0.46
IDO1 P14902 1/20 0.46
RIPK1 Q13546 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
MEN1 O00255 3/20 0.46
NPC1 O15118 1/20 0.46
GAA P10253 1/20 0.46
RAB9A P51151 1/20 0.46
TDP1 Q9NUW8 2/20 0.45
AHR P35869 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL836471 0.88 MAPT (0.52) MAPTKMT2AKDM4EALDH1A1POLB
SCHEMBL14945771 0.85 KMT2A (0.44) MAPTKMT2AKDM4EALDH1A1POLB
SCHEMBL11665388 0.78 KMT2A (0.47) MAPTKMT2AKDM4EALDH1A1POLB
SCHEMBL14935534 0.73 FPR2 (0.64)
SCHEMBL23253849 0.70 MEN1 (0.56) MAPTKMT2AKDM4EALDH1A1HPGD
SCHEMBL29413080 0.69 MEN1 (0.69) MAPTKMT2AKDM4EALDH1A1HPGD
SCHEMBL90504 0.69 MEN1 (0.69) MAPTKMT2AKDM4EALDH1A1HPGD
SCHEMBL13417709 0.67 MEN1 (0.44) MAPTKMT2AKDM4EALDH1A1CYP3A4
SCHEMBL10326754 0.66 MAPT (0.59) MAPTKMT2AKDM4EALDH1A1POLB
SCHEMBL837717 0.66 RIPK1 (0.79) MAPTKMT2AKDM4EALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170216393-A1 METHODS AND COMPOSITIONS FOR PRESERVING PHOTORECEPTOR AND RETINAL PIGMENT EPITHELIAL CELLS MASSACHUSETTS EYE AND EAR INFIRMARY 2017-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170216393-A1 METHODS AND COMPOSITIONS FOR PRESERVING PHOTORECEPTOR AND RETINAL PIGMENT EPITHELIAL CELLS ALDH1A2, PDE6B, PDE6C MAPT 1875/4885KMT2A 4268/4885KDM4E 4494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.